iAnthus Capital Holdings Inc. (C:IAN)
Business Focus: Medical Farming
| Sector: Healthcare | Industry: Healthcare Facilities & Services |
| Company Contact | |
| Address: | 420 Lexington Ave, Suite 414 NEW YORK NY 10170 |
| Tel: | N/A |
| Website: | https://www.ianthus.com |
| IR: | See website |
| Key People | ||
| Richard Proud Chief Executive Officer, Director | Justin Vu Interim Chief Financial Officer | |
| Business Overview |
| iAnthus Capital Holdings, Inc. is a vertically integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities. The Company is also a developer, producer, and distributor of branded cannabis and cannabidiol (CBD) products in the United States. Through its subsidiaries, the Company owns and/or operates 37 dispensaries and eight cultivation and/or processing facilities in seven United States. Its multi-state operations encompass a full range of medical and adult-use cannabis enterprises, including cultivation, processing, product development, wholesale-distribution, and retail. The Company offers various cannabis products, which includes flower and trim, products containing cannabis flower and trim, such as packaged flower and pre-rolls; cannabis infused products, such as topical creams and edibles and products containing cannabis extracts, such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures. |
| Financial Overview |
| For the fiscal year ended 31 December 2023, iAnthus Capital Holdings Inc revenues decreased 2% to $159.2M. Net loss decreased 83% to $76.6M. Revenues reflect Western Region segment decrease of 19% to $53.1M, Other segment decrease of 79% to $227K. Lower net loss reflects Loss on debt extinguishment decrease of 100% to $1.3M (expense), Impairment loss decrease from $30.6M (expense) to $0K. |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $341.29M as of Dec 31, 2023 |
| Annual revenue (TTM): | $219.27M as of Dec 31, 2023 |
| EBITDA (TTM): | -$17.15M as of Dec 31, 2023 |
| Net annual income (TTM): | -$105.51M as of Dec 31, 2023 |
| Free cash flow (TTM): | -$4.21M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | $209.54M as of Dec 31, 2023 |
| Shares outstanding: | 6,615,326,267 as of Apr 5, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
